rs1800566
Positions:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000903.3(NQO1):c.559C>T(p.Pro187Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.207 in 1,610,182 control chromosomes in the GnomAD database, including 37,821 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity,risk factor (no stars).
Frequency
Genomes: 𝑓 0.22 ( 3888 hom., cov: 32)
Exomes 𝑓: 0.21 ( 33933 hom. )
Consequence
NQO1
NM_000903.3 missense
NM_000903.3 missense
Scores
2
8
8
Clinical Significance
Conservation
PhyloP100: 9.29
Genes affected
NQO1 (HGNC:2874): (NAD(P)H quinone dehydrogenase 1) This gene is a member of the NAD(P)H dehydrogenase (quinone) family and encodes a cytoplasmic 2-electron reductase. This FAD-binding protein forms homodimers and reduces quinones to hydroquinones. This protein's enzymatic activity prevents the one electron reduction of quinones that results in the production of radical species. Mutations in this gene have been associated with tardive dyskinesia (TD), an increased risk of hematotoxicity after exposure to benzene, and susceptibility to various forms of cancer. Altered expression of this protein has been seen in many tumors and is also associated with Alzheimer's disease (AD). Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0031418502).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.43 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NQO1 | NM_000903.3 | c.559C>T | p.Pro187Ser | missense_variant | 6/6 | ENST00000320623.10 | NP_000894.1 | |
NQO1 | NM_001025433.2 | c.457C>T | p.Pro153Ser | missense_variant | 5/5 | NP_001020604.1 | ||
NQO1 | NM_001025434.2 | c.445C>T | p.Pro149Ser | missense_variant | 5/5 | NP_001020605.1 | ||
NQO1 | NM_001286137.2 | c.343C>T | p.Pro115Ser | missense_variant | 4/4 | NP_001273066.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NQO1 | ENST00000320623.10 | c.559C>T | p.Pro187Ser | missense_variant | 6/6 | 1 | NM_000903.3 | ENSP00000319788 | P1 |
Frequencies
GnomAD3 genomes AF: 0.216 AC: 32896AN: 151948Hom.: 3881 Cov.: 32
GnomAD3 genomes
AF:
AC:
32896
AN:
151948
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.252 AC: 62641AN: 248524Hom.: 9185 AF XY: 0.249 AC XY: 33426AN XY: 134474
GnomAD3 exomes
AF:
AC:
62641
AN:
248524
Hom.:
AF XY:
AC XY:
33426
AN XY:
134474
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.206 AC: 300203AN: 1458116Hom.: 33933 Cov.: 33 AF XY: 0.208 AC XY: 150960AN XY: 724570
GnomAD4 exome
AF:
AC:
300203
AN:
1458116
Hom.:
Cov.:
33
AF XY:
AC XY:
150960
AN XY:
724570
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.217 AC: 32929AN: 152066Hom.: 3888 Cov.: 32 AF XY: 0.223 AC XY: 16554AN XY: 74316
GnomAD4 genome
AF:
AC:
32929
AN:
152066
Hom.:
Cov.:
32
AF XY:
AC XY:
16554
AN XY:
74316
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
677
ALSPAC
AF:
AC:
768
ESP6500AA
AF:
AC:
856
ESP6500EA
AF:
AC:
1709
ExAC
AF:
AC:
29705
Asia WGS
AF:
AC:
1142
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity; risk factor
Submissions summary: Pathogenic:1Benign:1Other:3
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Breast cancer, post-chemotherapy poor survival in Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jul 01, 2008 | - - |
NQO1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 17, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Lung carcinoma Other:1
not provided, no classification provided | literature only | Database of Curated Mutations (DoCM) | Mar 10, 2016 | - - |
Leukemia, post-chemotherapy, susceptibility to Other:1
risk factor, no assertion criteria provided | literature only | OMIM | Jul 01, 2008 | - - |
Benzene toxicity, susceptibility to Other:1
risk factor, no assertion criteria provided | literature only | OMIM | Jul 01, 2008 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;.;T;.;.;T
Eigen
Uncertain
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D;D;D;D
MetaRNN
Benign
T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;.;L;.;.;.
MutationTaster
Benign
P;P;P;P;P;P
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D;D;D;D;D
REVEL
Uncertain
Sift
Benign
T;T;D;D;T;D
Sift4G
Benign
T;D;D;T;T;D
Polyphen
0.44, 1.0
.;.;B;.;D;.
Vest4
MPC
1.1
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at